Amorchem logo

Amorchem

North America, Quebec, Canada, Montréal

Description

A venture capital fund located in Montreal focused on creating promising life science companies.

Investor Profile

Amorchem has made 6 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Seed (33%)
  • Series C (17%)
  • Series B (17%)
  • Post Ipo Equity (17%)
  • Series A (17%)

Country Focus

  • Canada (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Medical
  • Pharmaceutical
  • Life Science
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Amorchem frequently co-invest with?

Fonds de solidarité FTQ
North America, Quebec, Canada, Montréal
Co-Investments: 3
Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Accel-Rx Health Sciences Accelerator
North America, British Columbia, Canada, Vancouver
Co-Investments: 2
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 1
AQC Capital
North America, Quebec, Canada, Montréal
Co-Investments: 3
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 2
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 3
Genesys Capital
North America, Ontario, Canada, Toronto
Co-Investments: 4
adMare Bio Innovations
North America, British Columbia, Canada, Vancouver
Co-Investments: 2
Anges Quebec
North America, Quebec, Canada, Quebec
Co-Investments: 2

What are some of recent deals done by Amorchem?

Inversago Pharma

Montréal, Quebec, Canada

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series COct 17, 2022
Amount Raised: $69,264,701
Giiant Pharma

Montréal, Quebec, Canada

Giiant Pharma is a preclinical-stage biotech company.

BiopharmaBiotechnologyHealth CareLife Science
SeedMay 21, 2021
Amount Raised: $12,429,875
Inversago Pharma

Montréal, Quebec, Canada

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BSep 8, 2020
Amount Raised: $35,000,000
Liminal BioSciences

Laval, Quebec, Canada

Liminal is a biopharmaceutical corporation supplying state-of-the-art technologies for bio-separations as well as therapeutic products.

BiotechnologyHealth DiagnosticsMedical
Post Ipo EquityJul 16, 2020
Amount Raised: $1,768,199
Inversago Pharma

Montréal, Quebec, Canada

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series AJul 25, 2018
Amount Raised: $7,000,000
SpecificiT Pharma

Montréal, Quebec, Canada

A privately held biopharmaceutical company.

BiotechnologyHealth CarePharmaceutical
SeedSep 11, 2017